Protein found to be the link missing between HPV infection and cervical cancer development

	Tweet

Most women are infected with human papillomavirus (HPV), which can cause cervical cancer - yet few develop the cancer. Now researchers at Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center, believe they have found the missing link explaining why: activation of the beta-catenin oncogene.

At the American Association for Cancer Research (AACR) 102nd Annual Meeting 2011, the researchers say that a new mouse model they developed demonstrates that switching the oncogene on in the cervix of HPV infected mice promoted development of aggressive cervical cancer.

These early findings suggest clinical implications that are both preventive and therapeutic, says the study’s senior investigator, Aykut Üren, M.D., an associate professor of oncology at Lombardi.

"We can potentially develop a screening method to check for HPV and beta-catenin activation in pap smears,” he says. “That will identify individuals at a higher risk of developing cancer compared to ones who are only HPV positive. Then they can be more closely followed for cancer development.”

Secondly, Üren points out that there are new drugs being developed to target the Wnt pathway that includes the beta-catenin protein. “Activation of this pathway is very common in colon cancer and is found in a dozen other cancers, so these same novel drugs might be useful in treating advanced stage cervical cancer patients,” he says.

Üren points out that while cervical cancer has been kept in check in the U.S. and other developed nations due to use of Pap smears and, of late, the HPV vaccine that protects uninfected females, cervical cancer is the second leading cause of cancer deaths in women worldwide. “New international approaches to control and treat cervical cancer are desperately needed,” he says.

Their novel mouse model was created by cross-breeding two other strains of transgenic mice – one that expresses HPV genes in the cervix and the other that forces the beta catenin/Wnt pathway to be constantly activated, also in the cervix. While the HPV infected mice are programmed to develop cervical cancer, the tumors that grew in the double transgenic mice were larger and more aggressive.

###

The study was funded by the National Cancer Institute. Gülay Bulut, Ph.D., a postdoctoral researcher in Üren’s laboratory, will present the results at a poster session.

The authors report having no personal financial interests related to the study.

About Lombardi Comprehensive Cancer Center

The Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Lombardi is one of only 41 comprehensive cancer centers in the nation, as designated by the National Cancer Institute, and the only one in the Washington, DC, area. For more information, go to http://lombardi.georgetown.edu.

About Georgetown University Medical Center

Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC’s mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis—or “care of the whole person.” The Medical Center includes the School of Medicine and the School of Nursing and Health Studies, both nationally ranked, the world-renowned Lombardi Comprehensive Cancer Center and the Biomedical Graduate Research Organization (BGRO).In fiscal year 2009-2010, GUMC accounted for 79 percent of Georgetown University’s extramural research funding.

###

Contact: Karen Mallet

215-514-9751
Georgetown University Medical Center

RELATED STORIES:
HPV screen-and treat-intervention effective in cervical cancer prevention   Cervical cancer risk higher in women on the pill   Post-treatment PET Scans Can Reassure Cervical Cancer Patients   Cervical disease sufferers could benefit from HPV vaccine   Doctors say HPV vaccine should be given to everyone   Weakened RNA Interference Reduces Survival in Ovarian Cancer   HPV tests better for cervical screening - experts   Obese women in Canada are less likely to be screened for cervical cancer   15 Common Myths About Cervical Cancer   HPV Vaccine Reduces Abnormal Pap Test Results   Cervical Cancer Rates Higher Among Minority Women   How Medical Center Research Led to New Cervical Cancer Vaccine   Aggressive vaccine effort could cut cervical cancer   Staging of cervical cancer complicating pregnancy   Genetic Differences Help Protect Against Cervical Cancer   Good results with cervical cancer vaccine in young girls   Aspirin Merits Testing for Prevention of Cervical Cancer in HIV-Infected Women   HPV Clearance Tied to Cervical Cancer Disparity   Cervical cancer drops, but disparities persist   Optimal Treatment and Minimal Complications in Cervical Cancer Patients   HIV drug stops cervical cancer in laboratory test   Study indicates vaccine prevents cervical cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]